Atopic Dermatitis (Atopic Eczema) in Children

Topic Introduction Epidemiology Pathophysiology Clinical Presentation Diagnosis Management Complications Prognosis

Introduction to Atopic Dermatitis in Children

Atopic dermatitis (AD), also known as atopic eczema, is a chronic, relapsing inflammatory skin condition characterized by pruritus, erythema, and skin barrier dysfunction. It is one of the most common skin disorders in children, often beginning in infancy and potentially persisting into adulthood. AD is part of the atopic triad, which also includes asthma and allergic rhinitis.

Key features of atopic dermatitis include:

• Pruritus (itching) - the hallmark symptom
• Characteristic age-dependent distribution of skin lesions
• Chronic or chronically relapsing course
• Personal or family history of atopy
• Associated cutaneous and extracutaneous complications

Understanding the multifaceted nature of AD is crucial for effective management and improving the quality of life for affected children and their families.

The nomenclature of dermatitis and its immunologically mediated forms eczema (immunologically mediated dermatitis), IgE-mediated eczema (atopic eczema), and non-IgE-mediated eczema (nonatopic eczema). (source)

Epidemiology of Atopic Dermatitis in Children

Atopic dermatitis is a global health concern, with increasing prevalence in many countries over the past few decades.

• Prevalence:
  • Affects 15-20% of children worldwide
  • Up to 3% of adults in developed countries
• Age of onset:
  • 60% of cases begin in the first year of life
  • 90% begin before 5 years of age
• Gender distribution: Slightly more common in females
• Geographical variation:
  • Higher prevalence in urban areas and developed countries
  • Lower prevalence in rural areas and developing countries
• Genetic factors:
  • 70% concordance in monozygotic twins
  • 30% concordance in dizygotic twins
• Risk factors:
  • Family history of atopic diseases
  • Environmental factors (pollution, climate)
  • Western lifestyle (diet, hygiene practices)

The increasing prevalence of AD underscores the importance of early recognition, proper management, and ongoing research into prevention strategies.

Pathophysiology of Atopic Dermatitis in Children

The pathophysiology of atopic dermatitis is complex and multifactorial, involving interactions between genetic predisposition, immune dysregulation, and environmental factors.

1. Genetic factors:
   • Mutations in the filaggrin (FLG) gene - crucial for skin barrier function
   • Polymorphisms in genes related to immune function (e.g., IL-4, IL-13, TSLP)
2. Skin barrier dysfunction:
   • Reduced natural moisturizing factors
   • Increased transepidermal water loss
   • Altered lipid composition in the stratum corneum
3. Immune dysregulation:
   • Th2-dominant immune response in acute phase
   • Increased IgE production
   • Elevated levels of pro-inflammatory cytokines (IL-4, IL-13, IL-31)
   • Reduced antimicrobial peptides
4. Neurogenic inflammation:
   • Increased nerve density in the epidermis
   • Enhanced release of pruritogenic mediators
5. Microbiome dysbiosis:
   • Increased Staphylococcus aureus colonization
   • Reduced microbial diversity

Understanding these pathophysiological mechanisms is crucial for developing targeted therapies and improving management strategies for atopic dermatitis in children.

Etiology and pathogenesis of atopic dermatitis. (source)

Clinical Presentation of Atopic Dermatitis in Children

The clinical presentation of atopic dermatitis in children varies with age and disease severity. Key features include:

1. Pruritus:
   • Hallmark symptom, often severe and persistent
   • May lead to sleep disturbances and irritability
2. Morphology of lesions:
   • Acute: erythematous papules and vesicles with excoriations
   • Subacute: erythematous, scaly, excoriated plaques
   • Chronic: lichenification, hyperpigmentation, and fibrotic papules
3. Age-dependent distribution:
   • Infants (0-2 years):
     • Face (cheeks, forehead)
     • Extensor surfaces of extremities
     • Trunk
   • Children (2-12 years):
     • Flexural areas (antecubital and popliteal fossae)
     • Neck, wrists, and ankles
   • Adolescents and adults:
     • Similar to children, with more prominent hand and foot involvement



Atopic dermatitis: clinical features.(source)



4. Associated features:
   • Xerosis (dry skin)
   • Dennie-Morgan folds (infraorbital folds)
   • Hyperlinear palms
   • Keratosis pilaris
   • Pityriasis alba
5. Exacerbating factors:
   • Environmental allergens (dust mites, pollen)
   • Irritants (soaps, detergents)
   • Climate changes (heat, humidity)
   • Stress
   • Infections (particularly S. aureus)

Recognizing the diverse clinical presentations and exacerbating factors is essential for accurate diagnosis and effective management of atopic dermatitis in children.

Diagnosis of Atopic Dermatitis in Children

The diagnosis of atopic dermatitis is primarily clinical, based on characteristic symptoms and signs. Several diagnostic criteria have been proposed, with the UK Working Party's Diagnostic Criteria being widely used.

UK Working Party's Diagnostic Criteria:

Must have:

• An itchy skin condition (or parental report of scratching or rubbing in a child)

Plus three or more of the following:

• History of involvement of the skin creases (e.g., folds of elbows, behind the knees)
• Personal history of asthma or hay fever (or history of atopic disease in a first-degree relative in children under 4 years)
• History of generally dry skin in the last year
• Visible flexural dermatitis (or dermatitis involving the cheeks/forehead and outer limbs in children under 4 years)
• Onset under the age of 2 years (not used if child is under 4 years)

Additional Diagnostic Considerations:

1. Clinical history:
   • Age of onset
   • Pattern and distribution of lesions
   • Family history of atopic diseases
   • Exacerbating factors
2. Physical examination:
   • Evaluate the extent and severity of skin lesions
   • Look for associated features (e.g., xerosis, Dennie-Morgan folds)
3. Severity assessment:
   • SCORAD (SCORing Atopic Dermatitis)
   • EASI (Eczema Area and Severity Index)
4. Laboratory tests (not routinely required):
   • Serum IgE levels
   • Specific IgE or skin prick tests for suspected allergens
5. Differential diagnosis:
   • Seborrheic dermatitis
   • Contact dermatitis
   • Psoriasis
   • Scabies
   • Cutaneous T-cell lymphoma (in persistent cases)

Accurate diagnosis is crucial for appropriate management and to differentiate atopic dermatitis from other skin conditions that may require different treatment approaches.

Management of Atopic Dermatitis in Children

The management of atopic dermatitis in children requires a multifaceted approach, focusing on skin barrier repair, inflammation control, and trigger avoidance.

1. Basic skin care:
   • Regular use of emollients (2-3 times daily)
   • Lukewarm baths with mild, fragrance-free cleansers
   • "Soak and smear" technique
   • Avoiding known irritants and allergens
2. Topical anti-inflammatory therapy:
   • Topical corticosteroids (TCS):
     • First-line treatment for flares
     • Potency selected based on severity and location
     • Potential side effects: skin atrophy, striae, telangiectasia
   • Topical calcineurin inhibitors (TCIs):
     • Tacrolimus and pimecrolimus
     • Useful for sensitive areas (face, genitals)
     • No risk of skin atrophy
3. Antipruritic treatments:
   • Oral antihistamines (e.g., cetirizine, fexofenadine)
   • Topical anesthetics (e.g., pramoxine) for short-term use
4. Infection management:
   • Topical or oral antibiotics for secondary bacterial infections
   • Antiviral therapy for eczema herpeticum
5. Systemic therapies (for severe, refractory cases):
   • Systemic corticosteroids (short courses)
   • Cyclosporine
   • Methotrexate
   • Azathioprine
   • Dupilumab (IL-4 and IL-13 inhibitor)
6. Phototherapy:
   • Narrowband UVB
   • Generally reserved for older children and adolescents
7. Non-pharmacological interventions:
   • Patient and family education
   • Psychological support
   • Behavior modification techniques for scratch control
8. Emerging therapies:
   • JAK inhibitors (e.g., abrocitinib, upadacitinib)
   • IL-31 receptor antagonists

Management should be tailored to the individual patient, considering factors such as age, disease severity, and impact on quality of life. Regular follow-up and adjustment of treatment plans are essential for optimal outcomes.

Complications of Atopic Dermatitis in Children

Atopic dermatitis can lead to various complications, both cutaneous and extracutaneous, which can significantly impact a child's health and quality of life.

1. Cutaneous complications:
   • Secondary bacterial infections:
     • Staphylococcus aureus (most common)
     • Streptococcus species
   • Viral infections:
     • Eczema herpeticum (Kaposi's varicelliform eruption)
     • Molluscum contagiosum
     • Eczema coxsackium
   • Fungal infections:
     • Dermatophytosis
     • Candidiasis
   • Contact dermatitis (to topical medications or emollients)
   • Ocular complications:
     • Blepharitis
     • Keratoconjunctivitis
     • Keratoconus
2. Extracutaneous complications:
   • Growth delay (in severe cases)
   • Sleep disturbances
   • Psychological issues:
     • Anxiety
     • Depression
     • Behavioral problems
   • Social isolation and stigmatization
   • Academic performance issues
3. Atopic comorbidities:
   • Asthma
   • Allergic rhinitis
   • Food allergies
4. Treatment-related complications:
   • Skin atrophy from prolonged topical corticosteroid use
   • Growth suppression from systemic corticosteroids
   • Increased susceptibility to skin infections
   • Potential long-term effects of immunosuppressive therapies
   • Burning or stinging sensation from topical calcineurin inhibitors
5. Long-term health implications:
   • Increased risk of cardiovascular diseases
   • Higher incidence of autoimmune disorders
   • Potential link to attention deficit hyperactivity disorder (ADHD)
6. Economic burden:
   • Direct medical costs (medications, doctor visits)
   • Indirect costs (lost productivity, time off work/school)
   • Out-of-pocket expenses for non-prescription treatments

Recognizing and addressing these complications is crucial for comprehensive management of atopic dermatitis in children. Early intervention and appropriate treatment can help mitigate many of these complications and improve long-term outcomes.

Prognosis of Atopic Dermatitis in Children

The prognosis of atopic dermatitis in children is generally favorable, but the course can be variable and unpredictable. Understanding the natural history and prognostic factors can help in managing expectations and guiding long-term care.

1. Natural history:
   • 40-60% of children with AD experience clearance or significant improvement by adolescence
   • 20-30% continue to have persistent symptoms into adulthood
   • Late-onset AD (after puberty) tends to be more persistent
2. Prognostic factors:
   • Early onset (before 2 years of age) is associated with a better prognosis
   • Severe disease in childhood predicts a higher likelihood of persistence
   • Presence of other atopic conditions (asthma, allergic rhinitis) may indicate a more prolonged course
   • Filaggrin gene mutations are associated with more severe and persistent disease
3. Long-term sequelae:
   • Post-inflammatory hyperpigmentation or hypopigmentation
   • Scarring (in severe cases with chronic scratching)
   • Persistent lichenification in chronic cases
4. Quality of life impact:
   • Improvement in symptoms often leads to significant enhancement in quality of life
   • Some patients may experience periodic flares even after long periods of remission
5. Atopic march:
   • AD is often the first manifestation of atopy in children
   • Many children with AD go on to develop other atopic conditions (asthma, allergic rhinitis)
   • Early and effective management of AD may potentially modify the atopic march
6. Factors influencing long-term outcomes:
   • Adherence to treatment regimens
   • Early initiation of appropriate therapy
   • Effective trigger avoidance
   • Psychosocial support and coping strategies

While the prognosis of atopic dermatitis in children is generally good, it's important to provide ongoing support and management. Regular follow-up, patient education, and adapting treatment strategies as the child grows can help optimize outcomes and minimize the impact of the disease on the child's overall health and well-being.

Objective QnA: Atopic Dermatitis (Atopic Eczema) in Children

1. What is atopic dermatitis?
   Answer: Atopic dermatitis is a chronic, inflammatory skin condition characterized by dry, itchy skin and recurrent eczematous lesions.
2. At what age does atopic dermatitis typically first appear in children?
   Answer: Atopic dermatitis usually appears within the first 6 months to 5 years of life, with most cases starting before age 2.
3. What are the three main factors contributing to atopic dermatitis?
   Answer: The three main factors are genetic predisposition, skin barrier dysfunction, and immune system dysregulation.
4. Which of the following is NOT a common location for atopic dermatitis in infants?
   Answer: Palms and soles of feet (Atopic dermatitis in infants typically affects the face, scalp, and extensor surfaces of extremities)
5. What is the "atopic march"?
   Answer: The "atopic march" refers to the typical progression of atopic diseases, starting with atopic dermatitis, followed by food allergies, allergic rhinitis, and asthma.
6. Which skin barrier protein is often deficient in patients with atopic dermatitis?
   Answer: Filaggrin
7. What is the primary symptom that defines atopic dermatitis?
   Answer: Intense itching (pruritus)
8. How does scratching contribute to the pathophysiology of atopic dermatitis?
   Answer: Scratching damages the skin barrier, leading to increased inflammation and susceptibility to infections, creating an "itch-scratch cycle".
9. What is the role of Staphylococcus aureus in atopic dermatitis?
   Answer: S. aureus often colonizes the skin of atopic dermatitis patients, exacerbating inflammation and increasing the risk of skin infections.
10. Which environmental factor is known to exacerbate atopic dermatitis symptoms?
    Answer: Low humidity
11. What is the first-line treatment for mild to moderate atopic dermatitis?
    Answer: Topical corticosteroids
12. How should topical corticosteroids be applied in relation to moisturizers?
    Answer: Topical corticosteroids should be applied before moisturizers.
13. What class of medications are tacrolimus and pimecrolimus?
    Answer: Topical calcineurin inhibitors
14. Which systemic medication might be considered for severe, refractory atopic dermatitis in children?
    Answer: Dupilumab (an IL-4 and IL-13 inhibitor)
15. What is the primary goal of using emollients in atopic dermatitis management?
    Answer: To improve and maintain skin barrier function
16. How often should children with atopic dermatitis bathe?
    Answer: Daily to every other day, using lukewarm water and mild, fragrance-free cleansers
17. What is the "soak and smear" technique?
    Answer: A method where the skin is soaked in water, patted dry, and then immediately covered with moisturizer to lock in hydration
18. Which clothing material is least likely to irritate atopic dermatitis?
    Answer: Cotton
19. What is the recommended first-line approach for managing nighttime itching in children with atopic dermatitis?
    Answer: Proper skin care, including regular use of emollients and appropriate topical anti-inflammatory treatments
20. Which of the following is NOT a common trigger for atopic dermatitis flares?
    Answer: Increased humidity (Common triggers include low humidity, stress, certain foods, allergens, and irritants)
21. What is the term for the dry, rough, bumpy skin often seen in patients with atopic dermatitis?
    Answer: Keratosis pilaris
22. How does the prevalence of atopic dermatitis change as children age?
    Answer: The prevalence tends to decrease with age, with many children outgrowing the condition by adolescence
23. What is the "weekend effect" in atopic dermatitis?
    Answer: The tendency for symptoms to worsen on weekends, often due to changes in routine and decreased adherence to treatment regimens
24. Which comorbidity is more common in children with atopic dermatitis compared to the general population?
    Answer: Attention deficit hyperactivity disorder (ADHD)
25. What is the primary mechanism of action for crisaborole in treating atopic dermatitis?
    Answer: Inhibition of phosphodiesterase-4 (PDE4)
26. How does wet wrap therapy work in managing severe atopic dermatitis flares?
    Answer: It involves applying topical medications and moisturizers, then covering the affected areas with damp and dry layers of cloth to increase penetration and reduce itching
27. What is the role of probiotics in atopic dermatitis management?
    Answer: While research is ongoing, some studies suggest probiotics may help prevent atopic dermatitis in high-risk infants and potentially reduce severity in some patients
28. Which vitamin deficiency has been associated with increased severity of atopic dermatitis?
    Answer: Vitamin D deficiency
29. What is the typical distribution of atopic dermatitis lesions in older children and adolescents?
    Answer: Flexural areas such as the neck, elbow creases, and behind the knees
30. How does the pH of the skin in atopic dermatitis patients differ from healthy individuals?
    Answer: The skin pH is typically higher (more alkaline) in atopic dermatitis patients
31. What is the name of the scoring system commonly used to assess the severity of atopic dermatitis in clinical trials?
    Answer: SCORAD (SCORing Atopic Dermatitis)
32. Which cytokines play a key role in the pathogenesis of atopic dermatitis?
    Answer: IL-4, IL-13, and IL-31
33. What is the recommended duration of topical corticosteroid use for an acute flare of atopic dermatitis?
    Answer: Typically 3-7 days, or until the flare is controlled
34. How does atopic dermatitis affect a child's quality of life?
    Answer: It can significantly impact sleep, social interactions, self-esteem, and academic performance due to itching, discomfort, and visible skin changes

Disclaimer

The notes provided on Pediatime are generated from online resources and AI sources and have been carefully checked for accuracy. However, these notes are not intended to replace standard textbooks. They are designed to serve as a quick review and revision tool for medical students and professionals, and to aid in theory exam preparation. For comprehensive learning, please refer to recommended textbooks and guidelines.